Patent directory · USPTO A61K / A61P
Patents matching “precision”
183 pharma patents match "precision" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 183 pharmaceutical patents matching "precision" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12419920
Bifidobacterium longum NCIMB 41676
granted -
US 12410418
Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
granted -
US 12404297
Salts and crystal forms of GABA-A positive allosteric modulator
granted -
US 12351839
Rationally-designed single-chain meganucleases with non-palindromic recognition sequences
granted -
US 12344676
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
granted -
US 12336835
Neuromodulation to target glucose transporter and/or incretin pathways
granted -
US 12325711
3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-α]pyrazine as an ion channel modulator
granted -
US 12259378
Dynamic clamps and methods of use thereof
granted -
US 12232492
Disinfection of bacteriophages products using supercritical carbon dioxide
granted -
US 12233135
Therapeutic constructs for treating cancer
granted -
US 12208227
Precision bio-chemotronic system
granted -
US 12180463
Lactobacillus reuteri
granted -
US 12162920
Hinge area and use of same in constructing car skeleton
granted -
US 12145939
Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulators
granted -
US 12077502
Formulations of T-type calcium channel modulators and methods of use thereof
granted -
US 12071516
Polymeric stabilizing formulations
granted -
US 12054501
Compositions and methods for inhibiting arginase activity
granted -
US 12037410
Methods and compositions for targeting Treg cells
granted -
US 12029577
Neuromodulation to target glucose transporter and/or incretin pathways
granted -
US 12012597
Cancer treatment using siRNA to modulate expression of PRDM2/RIZ protein
granted -
US 12006522
Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene
granted -
US 11993793
Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene
granted -
US 11952429
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
granted -
US 11931453
Drug delivery device
granted